These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25427859)

  • 1. Are the Norwegian health research investments in line with the disease burden?
    Kinge JM; Roxrud I; Vollset SE; Skirbekk V; Røttingen JA
    Health Res Policy Syst; 2014 Nov; 12():64. PubMed ID: 25427859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
    Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
    BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Investments in Global Health: A Systematic Analysis of UK Infectious Disease Research Funding and Global Health Metrics, 1997-2013.
    Head MG; Fitchett JR; Nageshwaran V; Kumari N; Hayward A; Atun R
    EBioMedicine; 2016 Jan; 3():180-190. PubMed ID: 26870829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic losses and burden of disease by medical conditions in Norway.
    Kinge JM; Sælensminde K; Dieleman J; Vollset SE; Norheim OF
    Health Policy; 2017 Jun; 121(6):691-698. PubMed ID: 28461038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK investments in global infectious disease research 1997-2010: a case study.
    Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
    Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
    Head MG; Brown RJ; Newell ML; Scott JAG; Batchelor J; Atun R
    Lancet Glob Health; 2020 Oct; 8(10):e1295-e1304. PubMed ID: 32971052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden?
    Mitchell RJ; McClure RJ; Olivier J; Watson WL
    Med J Aust; 2009 Dec 7-21; 191(11-12):648-52. PubMed ID: 20028294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific health spending by age, sex, and type of care in Norway: a national health registry study.
    Kinge JM; Dieleman JL; Karlstad Ø; Knudsen AK; Klitkou ST; Hay SI; Vos T; Murray CJL; Vollset SE
    BMC Med; 2023 Jun; 21(1):201. PubMed ID: 37277874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study 2013.
    Karimkhani C; Wanga V; Coffeng LE; Naghavi P; Dellavalle RP; Naghavi M
    Lancet Infect Dis; 2016 May; 16(5):584-591. PubMed ID: 26879176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of disease, research funding and innovation in the UK: Do new health technologies reflect research inputs and need?
    Ward D; Martino O; Packer C; Simpson S; Stevens A
    J Health Serv Res Policy; 2013 Apr; 18(1 Suppl):7-13. PubMed ID: 27552774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Neurological Disorders Collaborator Group
    Lancet Neurol; 2017 Nov; 16(11):877-897. PubMed ID: 28931491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.
    Soerjomataram I; Lortet-Tieulent J; Parkin DM; Ferlay J; Mathers C; Forman D; Bray F
    Lancet; 2012 Nov; 380(9856):1840-50. PubMed ID: 23079588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.
    India State-Level Disease Burden Initiative Collaborators
    Lancet; 2017 Dec; 390(10111):2437-2460. PubMed ID: 29150201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Mokdad AH; Forouzanfar MH; Daoud F; Mokdad AA; El Bcheraoui C; Moradi-Lakeh M; Kyu HH; Barber RM; Wagner J; Cercy K; Kravitz H; Coggeshall M; Chew A; O'Rourke KF; Steiner C; Tuffaha M; Charara R; Al-Ghamdi EA; Adi Y; Afifi RA; Alahmadi H; AlBuhairan F; Allen N; AlMazroa M; Al-Nehmi AA; AlRayess Z; Arora M; Azzopardi P; Barroso C; Basulaiman M; Bhutta ZA; Bonell C; Breinbauer C; Degenhardt L; Denno D; Fang J; Fatusi A; Feigl AB; Kakuma R; Karam N; Kennedy E; Khoja TA; Maalouf F; Obermeyer CM; Mattoo A; McGovern T; Memish ZA; Mensah GA; Patel V; Petroni S; Reavley N; Zertuche DR; Saeedi M; Santelli J; Sawyer SM; Ssewamala F; Taiwo K; Tantawy M; Viner RM; Waldfogel J; Zuñiga MP; Naghavi M; Wang H; Vos T; Lopez AD; Al Rabeeah AA; Patton GC; Murray CJ
    Lancet; 2016 Jun; 387(10036):2383-401. PubMed ID: 27174305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research investments for UK infectious disease research 1997-2013: A systematic analysis of awards to UK institutions alongside national burden of disease.
    Head MG; Brown RJ; Clarke SC
    J Infect; 2018 Jan; 76(1):11-19. PubMed ID: 29061335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.
    Sampson UK; Fowkes FG; McDermott MM; Criqui MH; Aboyans V; Norman PE; Forouzanfar MH; Naghavi M; Song Y; Harrell FE; Denenberg JO; Mensah GA; Ezzati M; Murray C
    Glob Heart; 2014 Mar; 9(1):145-158.e21. PubMed ID: 25432124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To what extent is health and medical research funding associated with the burden of disease in Australia?
    Aoun S; Pennebaker D; Pascal R
    Aust N Z J Public Health; 2004 Feb; 28(1):80-6. PubMed ID: 15108752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Burden and Socioeconomic Disparities From Hearing Loss: A Global Perspective.
    Ramsey T; Svider PF; Folbe AJ
    Otol Neurotol; 2018 Jan; 39(1):12-16. PubMed ID: 29210951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study.
    Smith E; Hoy DG; Cross M; Vos T; Naghavi M; Buchbinder R; Woolf AD; March L
    Ann Rheum Dis; 2014 Aug; 73(8):1462-9. PubMed ID: 24590181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of disease in young people aged 10-24 years: a systematic analysis.
    Gore FM; Bloem PJ; Patton GC; Ferguson J; Joseph V; Coffey C; Sawyer SM; Mathers CD
    Lancet; 2011 Jun; 377(9783):2093-102. PubMed ID: 21652063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.